Metabolic Screening in Patients With Donnai-Barrow Syndrome

NCT01509287 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2022-11-22

No results posted yet for this study

Summary

This study focuses on the genetics and metabolism of Donnai-Barrow Syndrome (DBS).

Conditions

  • Donnai-Barrow Syndrome

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Barbara Pober, MD · Massachusetts General Hospital

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01509287 on ClinicalTrials.gov